ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

ClinicalTrials.gov ID: NCT04662255

Public ClinicalTrials.gov record NCT04662255. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator Choice of BTK Inhibitor in Patients With Previously Treated BTK Inhibitor Naïve Mantle Cell Lymphoma (BRUIN MCL-321)

Study identification

NCT ID
NCT04662255
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Loxo Oncology, Inc.
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

  • Acalabrutinib Drug
  • Ibrutinib Drug
  • Pirtobrutinib Drug
  • Zanubrutinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 7, 2021
Primary completion
Dec 31, 2026
Completion
Mar 31, 2028
Last update posted
May 27, 2025

2021 – 2028

United States locations

U.S. sites
36
U.S. states
22
U.S. cities
35
Facility City State ZIP Site status
Alaska Oncology and Hematology, LLC Anchorage Alaska 99508
Arizona Oncology Associates, P.C. - HOPE Phoenix Arizona 85013
UCLA Medical Center Los Angeles California 90095
USO-Rocky Mountain Cancer Center Denver Colorado 80218
Mayo Clinic in Florida Jacksonville Florida 32224
Oncology-Hematology Associates of West Broward Tamarac Florida 33321
Florida Cancer Specialists East West Palm Beach Florida 33401
University of Kentucky Markey Cancer Center Lexington Kentucky 40504
Mercy Health-Paducah Medical Oncology and Hematology Paducah Kentucky 42003
Tulane Cancer Center Office of Clinical Research New Orleans Louisiana 70112
Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201
DFCI Lymphoma Boston Massachusetts 02115
Karmanos Cancer Institute Detroit Michigan 48201
Mayo Clinic Rochester Minnesota 55905-0002
Washington University Medical School St Louis Missouri 63110
Columbia University Medical Center New York New York 10032
Memorial Sloan Kettering Cancer Center New York New York 10065
Messino Cancer Center Asheville North Carolina 28806
Levine Cancer Institute Charlotte North Carolina 28204
Wake Forest University School of Medicine Winston-Salem North Carolina 27157-1045
Oncology Hematology Care Inc Cincinnati Ohio 45219
Willamette Valley Cancer Institute & Research Ctr. Eugene Oregon 97401
Sarah Cannon Research Institute SCRI Nashville Tennessee 37203
Texas Oncology-Austin Midtown Austin Texas 78705
Texas Oncology - Bedford Bedford Texas 76022
University of Texas MD Anderson Cancer Center Houston Texas 77030
Texas Oncology - McAllen McAllen Texas 78503
Texas Oncology - Sherman Sherman Texas 75090
US Oncology The Woodlands Texas 77380
Texas Oncology - Tyler Tyler Texas 75702
Huntsman Cancer Institute Salt Lake City Utah 84112
University of Virginia Health System Charlottesville Virginia 22903
USO-Virginia Cancer Specialists, PC Fairfax Virginia 22031
Seattle Cancer Care Alliance Seattle Washington 98109
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53705-2254
Froedtert Memorial Lutheran Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 153 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04662255, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 27, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04662255 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →